SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

40.04

965.76

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.06

Back

Foseco Crucible (India) standalone net profit rises 61.96% in the September 2026 quarter

Oct 29,2026

Net profit of Foseco Crucible (India) rose 61.96% to Rs 14.22 crore in the quarter ended September 2026 as against Rs 8.78 crore during the previous quarter ended September 2025. Sales rose 15.78% to Rs 53.18 crore in the quarter ended September 2026 as against Rs 45.93 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	53.18	45.93	16
OPM %	35.88	27.82	-
PBDT	20.64	15.25	35
PBT	18.08	12.43	45
NP	14.22	8.78	62

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)